Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning

Journal of Nuclear Medicine

Volumn 38, Issue 11, 1997, Pages 1762-1767

  Kabalka, George W ^a   Smith, Gary T ^a   Dyke, Jonathan P ^a   Reid, William S ^a   Longford, C P Desmond ^a   Roberts, Tony G ^a   Reddy, N Kesavulu ^a   Buonocore, Edward ^a   Hübner, Karl F ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Boron neutron capture therapy; Fluorine 18 BPA fructose; Positron emission tomography

Indexed keywords

FLUORINE 18;

ARTICLE; BIOPSY; CALCULATION; CASE REPORT; CLINICAL TRIAL; DOSE RESPONSE; DOSIMETRY; GLIOBLASTOMA; HUMAN; MELANOMA; NEUTRON CAPTURE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT PLANNING;

BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; FRUCTOSE; GLIOBLASTOMA; HUMANS; MIDDLE AGED; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030712915     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barth RF, Soloway AH, Fairchild RG. Boron neutron capture therapy of cancer. Cancer Res 1990;50:1061-1070.
2. Barth RF, Soloway AH, Fairchild RG, Brugger RM. Boron neutron capture therapy of cancer: present realities and future prospects. Cancer 1992;70;2995-3007.
3. Hatanaka H, Nakagawa Y. Clinical results of long surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 1994;28:1061-1066.
4. Fair LE, Sweet WH, Robertson JS, et al. Neutron capture therapy with boron in the treatment of glioblastoma multiforme. Roentgenol 1954;71:1279-1293.
5. Coderre JA, Bergland R, Chadha M, et al. Boron neutron capture of glioblastoma multiforme using p-boronophenylalanine-fructose complex and epithermal neutrons. In: Mishima Y, ed. Cancer Neutron Capture Therapy. New York: Plenum Press. 1996:553-561.
6. Kabalka GW, Davis M, Bendel P. Boron-11 MRI and MRS of intact animals infused with a boron neutron capture agent. J Magn Reson Med 1988;8:231-237.
7. Kabalka GW, Cheng CQ, Bendel P, Micca PL, Slatkin DN. In-Vivo Boron-11 MRI and MRS using (B24H22S2)4-in the rat. J Magn Reson Imag 1991;9:969-973.
8. Kabalka GW, Chao T, Bendel P. The role of boron MRI in boron neutron capture therapy. J Neuro Oncol 1997;33:153-161.
9. Bradshaw KM, Schweizer MP, Glover GH, et al. BSH distributions in the canine head and a human patient using B-11 MRI. Mag Reson Med 1995;34:48-56.
10. Hubner KF, King P, Gibbs WE, Partain CL, Washburn LC, Hayes RL, Holloway E. Clinical investigation with carbon-11-labeled amino acids using positron emission computerized tomography in patients with neoplastic disease. IAWA/WHO Symposium Proceedings, Vienna, 1981:515-529.
11. 11C-labeled amino acids. J Comput Assist Tomography 1982;6:544-550.
12. Hubner KF, Smith GT, Thie JA, Stephens TS, Buonocore E. Dynamic positron emission tomography (PET) of brain tumors using 1-aminocyclobutane[C-11]-carboxylic acid (1-[C-11]-ACBC) and a two-compartment model. J Nucl Med 1992;33:922.
13. Hubner KF, J Thie, Hunter K, Smith GT, Bond H. Mechanism of uptake of 1-[C-11]-aminocyclobutanecarboxylic acid (C-11-ACBC) by brain tumors examined by a new multiple time graphical analysis (MTGA) of image data acquired by positron emission tomography. In: Faulkner K, Carey B, Crellin A, et al., eds. Proceedings of the 19th L.H. Gray Conference: Quantitative Imaging in Oncology, London: British Institute of Radiology. 1996; 20-22.
14. Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y. Synthesis and radiation dosimetry of 4-borono-2-[F-18]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy. Appl Radial Isot 1991;42:325-328.
15. Reddy NK, Kabalka GW, Longord CPD, Roberts J, Timothy Gotsick. 4-[B-10]Borono-2-[F-18]fluoro-L-phenylalanine-fructose complex for use in timing boron neutron capture therapy (BNCT). J Labelled Compd Radiopharm 1995;37:599-600.
16. Smith GT, Jones RC, Hubner KF, Bond HW. A simple method to determine arterial input function data in quantitative PET [Abstract]. Proceedings of the Radiological Society of North America 80th Scientific Assembly and Annual Meeting 1995:326.
17. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomography 1979;3:299-308.
18. Imahori Y, Ueda S, Ohmori Y, et al. A basic concept for a PET-BNCT system. In: Mishima Y, ed. Cancer neutron capture therapy. New York: Plenum Press; 1996:691-696.
19. Huang SC, Phelps ME, Hoffman EJ, et al. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
20. Mankoff DA, Shields AF, Graham MM, Link JM, Krohn KA. A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites. J Nucl Med 1996;37:2049-2057.
21. Coderre JA, Morris GM, Micca PL, Fisher CD, Ross GM. Comparative assessment of single-dose and fractionated boron neutron capture therapy. Radiation Research 1995;144:310-317.
22. Barth RF, Adams DM, Soloway AH, Mechetner EB, Elam F, Anisuzzman ALM. Determination of boron in tissues and cells using direct current plasma atomic absorption emission spectroscopy. Anal Chem 1991;63:890-892.
23. Ishiwata K, Ido T, Kawamura M, Kubota K, Ichihashi M, Mishima Y. 4-boron-2-[F-18]flouoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. Int J Radiat Appl Instrum B 1991;18:745-751.
24. Ishiwata K, Shiono M, Kubota K, et al. A unique in vivo assessment of 4-[B-10]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[F-18]fluoro-L-phenylalanine. Melanoma Res 1992;2:171-174.
25. 99mTc-hexamethyl-propylene amine oxime in the human brain. J Cereb Blood Flow Metab 1988;8 (suppl):S61-S68.
26. Neirinckx RD, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen NA. The retention mechanism of technetium-99m-HMPAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab 1988;8 (suppl):S4-S12.
27. Smith GT, Stubbs JB, Hubner KF, Goodman MM. Dynamic PET scanning and compartmental model analysis to determine cellular level radiotracer distribution in vivo. Proceedings of the Fifth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN May 1991:371-384.
28. Stubbs JB, Smith GT, Stabin MG, Eckerman KF, Turner JE. An approach to cellular level dosimetry using compartmental model analysis and dynamic PET. Proceedings of the Fifth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN May 1991:385-395.
29. Nigg DW, Eng D. Methods for radiation dose distribution analysis and treatment planning in boron neutron capture therapy. Int J Radiation Oncology Biol Phys 1994;28:1121-1134.
30. Kobayashi T, Kanda K. Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy. Radiation Research 1982;91:77-94.